Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-046790

Chief Executive Officer acquired 1,529 shares (other)

  • Chief Executive Officer gave up 963 shares (to pay taxes)
  • Chief Executive Officer acquired 3,645 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Quart Barry D Chief Executive Officer 2021-04-30 Other acquisition +1,529 $13.90 $21,249 96,721 D
Quart Barry D Chief Executive Officer 2021-07-13 Option exercise +3,645 100,366 D
Quart Barry D Chief Executive Officer 2021-07-13 Shares withheld for taxes −963 $13.48 $12,981 99,403 D
Derivatives
Quart Barry D Chief Executive Officer 2021-07-13 Option exercise · Restricted Stock Units −3,645 47,396 D
Loading xslF345X03/doc4.xml…